Dolly Parton's Healthcare Legacy, Paxlovid for Long COVID, and Back-to-School Vaccinations

In this episode, Dr. Chi-Ming Chow reflects on Dolly Parton's legacy in healthcare, emphasizing the importance of patient-centered care and adaptability. He discusses personal branding, motivation, and humor in medicine, drawing parallels with Dolly Parton's authenticity and trust-building. The episode reviews a study on Paxlovid for treating long COVID, detailing the RECOVER-VITAL trial's findings and implications. Dr. Chow addresses back-to-school vaccinations, highlighting concerns over declining immunization rates and regional measles outbreak risks. The episode also examines a study on cannabis edibles and driving impairment, discussing participant responses and policy implications. The episode concludes with closing remarks.